Advances in HBV Disease Management
Schedule Telemedicine Consult with Dr. Gish Powered byTelemed2U
Powered byTelemed2U

Advances in HBV Disease Management

THE ADVENT OF TAF AS THE NEW THERAPY FOR CHRONIC HEPATITIS B BACKED BY USER EXPERIENCES

View PPT Deck


Article Metadata

Without a cure, most people who start CHB treatment must continue indefinitely. Accordingly, CHB management has to account for the changing needs of the patients over their lifetimes, including aging and the development of comorbidities. Since CHB therapy was first approved in the 1990s, we’ve seen continual advances in treatment options over the years. VEMLIDY is the first CHB drug approved since VIREAD was approved in 2008.